Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative Activity

Protein disulfide isomerase (PDI) is a member of the thioredoxin superfamily of redox enzymes. PDI is a multifunctional protein that catalyzes disulfide bond formation, cleavage, and rearrangement in unfolded or misfolded proteins and functions as a chaperone in the endoplasmic reticulum. Besides ac...

Full description

Saved in:
Bibliographic Details
Main Authors: Mariateresa Badolato, Gabriele Carullo, Francesca Aiello, Antonio Garofalo
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Chemistry
Online Access:http://dx.doi.org/10.1155/2017/2370359
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556780004048896
author Mariateresa Badolato
Gabriele Carullo
Francesca Aiello
Antonio Garofalo
author_facet Mariateresa Badolato
Gabriele Carullo
Francesca Aiello
Antonio Garofalo
author_sort Mariateresa Badolato
collection DOAJ
description Protein disulfide isomerase (PDI) is a member of the thioredoxin superfamily of redox enzymes. PDI is a multifunctional protein that catalyzes disulfide bond formation, cleavage, and rearrangement in unfolded or misfolded proteins and functions as a chaperone in the endoplasmic reticulum. Besides acting as a protein folding catalyst, several evidences have suggested that PDI can bind small molecules containing, for example, a phenolic structure, which includes the estrogenic one. Increasing studies indicate that PDI is involved in both physiology and pathophysiology of cells and tissues and is involved in the survival and proliferation of different cancers. Propionic acid carbamoyl methyl amides (PACMAs) showed anticancer activity in human ovarian cancer, both in vitro and in vivo, by inhibiting PDI. The inhibition of PDI’s activity may have a therapeutic role, in various diseases, including cancer. In the present study, we designed and synthesized a diversified small library of compounds with the aim of identifying a new class of PDI inhibitors. Most of synthesized compounds showed a good inhibitory potency against PDI and particularly 4-methyl substituted 2,6-di-tert-butylphenol derivatives (8–10) presented an antiproliferative activity in a wide panel of human cancer cell lines, including ovarian ones.
format Article
id doaj-art-e25db0996b4d4c1b869db907fc44d346
institution Kabale University
issn 2090-9063
2090-9071
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Chemistry
spelling doaj-art-e25db0996b4d4c1b869db907fc44d3462025-02-03T05:44:29ZengWileyJournal of Chemistry2090-90632090-90712017-01-01201710.1155/2017/23703592370359Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative ActivityMariateresa Badolato0Gabriele Carullo1Francesca Aiello2Antonio Garofalo3Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, ItalyDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, ItalyDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, ItalyDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, ItalyProtein disulfide isomerase (PDI) is a member of the thioredoxin superfamily of redox enzymes. PDI is a multifunctional protein that catalyzes disulfide bond formation, cleavage, and rearrangement in unfolded or misfolded proteins and functions as a chaperone in the endoplasmic reticulum. Besides acting as a protein folding catalyst, several evidences have suggested that PDI can bind small molecules containing, for example, a phenolic structure, which includes the estrogenic one. Increasing studies indicate that PDI is involved in both physiology and pathophysiology of cells and tissues and is involved in the survival and proliferation of different cancers. Propionic acid carbamoyl methyl amides (PACMAs) showed anticancer activity in human ovarian cancer, both in vitro and in vivo, by inhibiting PDI. The inhibition of PDI’s activity may have a therapeutic role, in various diseases, including cancer. In the present study, we designed and synthesized a diversified small library of compounds with the aim of identifying a new class of PDI inhibitors. Most of synthesized compounds showed a good inhibitory potency against PDI and particularly 4-methyl substituted 2,6-di-tert-butylphenol derivatives (8–10) presented an antiproliferative activity in a wide panel of human cancer cell lines, including ovarian ones.http://dx.doi.org/10.1155/2017/2370359
spellingShingle Mariateresa Badolato
Gabriele Carullo
Francesca Aiello
Antonio Garofalo
Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative Activity
Journal of Chemistry
title Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative Activity
title_full Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative Activity
title_fullStr Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative Activity
title_full_unstemmed Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative Activity
title_short Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative Activity
title_sort synthesis and experimental validation of new pdi inhibitors with antiproliferative activity
url http://dx.doi.org/10.1155/2017/2370359
work_keys_str_mv AT mariateresabadolato synthesisandexperimentalvalidationofnewpdiinhibitorswithantiproliferativeactivity
AT gabrielecarullo synthesisandexperimentalvalidationofnewpdiinhibitorswithantiproliferativeactivity
AT francescaaiello synthesisandexperimentalvalidationofnewpdiinhibitorswithantiproliferativeactivity
AT antoniogarofalo synthesisandexperimentalvalidationofnewpdiinhibitorswithantiproliferativeactivity